ProMIS Neurosciences (PMN) separated with Gavin T. Malenfant as Chief Operating Officer of the Company, effective as of February ...
StockNews.com began coverage on shares of Minerva Neurosciences (NASDAQ:NERV – Get Free Report) in a research report issued to clients and investors on Saturday. The firm set a “sell” rating on the ...
Minerva Neurosciences (NASDAQ:NERV – Get Free Report) is anticipated to post its quarterly earnings results before the market ...
MAHE, Manipal Introduces Integrated B.Sc. to M.Sc. Program in Clinical and Computational Neurosciences - The Manipal Academy ...
生物制品公司Klotho Neurosciences, Inc.因未能满足交易所最低市值要求，面临从纳斯达克全球市场摘牌的风险。该公司股价在过去一年暴跌96%至$0.38，市值缩水至仅851万美元。根据 InvestingPro 数据显示，该股票通常与大盘走势相反，贝塔值为-0.23。该公司此前曾用名为ANEW Medical, Inc.和Redwoods Acquisition ...
The recent volatility in our stock appears to be driven by misconceptions and a lack of understanding about our business and long-term strategy, but I want to reassure our investors that there have ...
Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...
Endeavor Health has named David Rahija, Endeavor Health Medical Group Operations president, as the next president of Endeavor ...
Trinity Health Ann Arbor has announced a significant $10 million donation from an anonymous donor to establish a new neurosciences institute on its hospital campus.
ProMIS Neurosciences Inc.宣布其首席运营官（COO）Gavin T. Malenfant将于2025年2月14日离职。该微型市值公司目前估值为3100万美元，股价接近52周低点0.88美元，在纳斯达克资本市场上以代码NASDAQ:PMN交易。该公司周三通过向美国证券交易委员会提交的8-K表格公布了这一消息。
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback